A study on the safety and effectiveness of transcatheter arterial chemoembolization and bevacizumab arterial infusion combined comprehensive treatment for hepatocellular carcinoma [0.03%]
经导管动脉化疗栓塞联合贝伐单抗肝动脉灌注综合治疗的安全性及疗效研究
Bingzheng Yan,Zhikai Yang,Cong Liu et al.
Bingzheng Yan et al.
Introduction and objectives: To evaluate the safety and efficacy of transcatheter arterial chemoembolization (TACE) combined with intra-arterial bevacizumab infusion in patients with advanced hepatocellular carcinoma (HCC...
Jesús Ruiz-Manríquez,Sandra M Feria-Agudelo,Antonio Olivas-Martinez et al.
Jesús Ruiz-Manríquez et al.
Background: Up to 15% of liver biopsies may reveal granulomas. The underlying causes vary geographically, with marked differences between high- and low-middle-income countries. No studies have examined the etiology of gra...
Alterations in one-carbon metabolism in metabolic dysfunction associated steatotic liver disease may be modified by semaglutide [0.03%]
与代谢功能障碍相关性肝脂肪变性疾病的一碳代谢改变可能通过索马鲁肽进行调节
Mikkel Parsberg Werge,Adrian McCann,Elias Badal Rashu et al.
Mikkel Parsberg Werge et al.
Introduction and objectives: Disruptions in one-carbon metabolism (OCM) have been linked to cardiometabolic diseases. We evaluated alterations in OCM metabolites and enzymes and the impact of semaglutide in MASLD. ...
Changing profile and burden of hepatocellular carcinoma in Arab Countries in 1990-2021 [0.03%]
阿拉伯国家1990-2021年肝细胞癌发病和疾病负担变化趋势研究
Ziyan Pan,Abdulla Al Hassani,Mona H Ismail et al.
Ziyan Pan et al.
Introduction and objectives: Hepatocellular carcinoma (HCC) remains a major health burden in Arab countries, with notable shifts in etiology and epidemiology over recent decades. This study evaluates the changing burden a...
The story of hepatitis E virus infection and chronic kidney disease without liver damage [0.03%]
感染戊型肝炎病毒的无肝损伤慢性肾病患者的故事
Addi P Figueroa-Miranda,Edgar D Copado-Villagrana,Nora A Fierro
Addi P Figueroa-Miranda
Primary biliary cholangitis has the worst quality of life indicators among the autoimmune liver diseases: A United States cohort [0.03%]
自身免疫性肝病中，原发性胆汁性胆管炎的生活质量指标最差：一项美国队列研究
Leandro Sierra,Bryan Ferrigno,Ana Marenco-Flores et al.
Leandro Sierra et al.
Introduction and objectives: Autoimmune liver diseases (AILDs) affect health-related quality of life (HRQOL). This seven-year, prospective study analyzes the impact of AILDs on HRQOL. ...
Demographic and clinical characteristics of MASLD and Met-ALD patients: Insights from NHANES 2017-2020 [0.03%]
2017-2020年NHANES代谢相关脂肪性肝病和代偿期肝硬化的临床与人口学特征分析
Jing Liang,Huning Xu,Xueqi Li et al.
Jing Liang et al.
Introduction and objectives: Recent reclassifications of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic-associated alcoholic liver disease (Met-ALD) have prompted the need for better charac...
Secular trends and survival impact of high proportion of curative treatments for hepatocellular carcinoma in Taiwan, 2011-2019 [0.03%]
台湾2011-2019年肝细胞癌治愈性治疗比例变化及其生存影响
Kwong-Ming Kee,Chien-Hung Chen,Tsang-Wu Liu et al.
Kwong-Ming Kee et al.
Introduction and objectives: To explore the secular trend and impact of treatment modalities for hepatocellular carcinoma (HCC) on survival in Taiwan. Mat...